linaclotide acetate

DRUG3 trials

Sponsors

Ironwood Pharmaceuticals, Inc., Mayo Clinic

Conditions

Chronic ConstipationColorectal CancerHealthy, no Evidence of DiseaseIrritable Bowel Syndrome With Constipation

Phase 1

Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers

CompletedNCT01950403

Mayo ClinicColorectal Cancer, Healthy, no Evidence of Disease

Start: 2013-09-30End: 2018-02-22Updated: 2024-12-09

Phase 2

Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation

CompletedNCT00402337

Ironwood Pharmaceuticals, Inc.Chronic Constipation

Start: 2006-11-30End: 2008-02-29Updated: 2013-03-05

Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

CompletedNCT00460811

Ironwood Pharmaceuticals, Inc.Irritable Bowel Syndrome With Constipation

Start: 2007-04-30End: 2008-04-30Updated: 2013-02-04

Related Papers

S510 Time to Relief of Key Abdominal and Bowel Symptoms of Irritable Bowel Syndrome with Constipation: A Post-Hoc Analysis of Randomized Controlled Trials of Linaclotide

The American Journal of Gastroenterology2021-10-011 citations

S529 Linaclotide Improves Symptoms of Irritable Bowel Syndrome With Constipation, Irrespective of Severity and Age: A Post-Hoc Analysis of Pooled Trials

The American Journal of Gastroenterology2021-10-01